Source: MS Trust The next step in the approval process is for the European Commission to grant a licence for cladribine, taking into consideration the EMA’s recommendation. Cladribine will then have to be appraised by NICE and the SMC to determine availability in the UK. In anticipation of the granting of a licence, NICE have already started the appraisal process and […]
European licence recommended for Cladribine (Mavenclad) Read More »
Source: Multiple Sclerosis News Today A variation in the NLRP1 gene is associated with multiple sclerosis that runs in families, Slovenian researchers report.
Researchers Find Gene Mutation in Multiple Sclerosis That Runs in Families Read More »
Source Israel21c Israeli scientists discover an abnormality in neurons’ protective membrane may enable the immune system to launch a mistaken attack.
Multiple sclerosis study reveals possible trigger Read More »
Source MS Society Globally acclaimed conductor, Daniel Barenboim, has announced a second performance at the Royal Festival Hall this October to raise funds for MS research.
Book now for Jacqueline du Pré Tribute concert raising money for MS research. Read More »
Source MS Trust A headline in the Daily Mirror makes claims for an experimental treatment that are not yet backed up by research.
Talk of a cure is premature Read More »
I would like to invite you to take part in a research project being carried out at the Berkshire MS Therapy Centre: the iStep-MS trial. This project is being carried out to find out how physiotherapists can best help people with MS to increase the amount of physical activity they do in a safe and
Source MS Society We’re proud to be co-funding the phase 3 trial to test if simvastatin could become a treatment for secondary progressive MS. This phase 3 trial will involve over 1000 people with secondary progressive MS.
Multi-million pound trial to investigate if statins could become MS treatment Read More »
Source The Telegraph: Statins could soon be prescribed to treat multiple sclerosis after a groundbreaking trial began to see if the cheap cholesterol busting drug could delay symptoms.
Statins could soon treat multiple sclerosis as ‘momentous’ trial begins Read More »
Source The Telegraph: British scientists have discovered a potential cause for multiple sclerosis, in a major breakthrough that could pave the way for new treatments for the disease.
Source BBC: Scientists hope they have found a drug to stop all neurodegenerative brain diseases, including dementia.
New drug for neurodegenerative disease is being developed Read More »
